Week 1: Drug Metabolism Flashcards

1
Q

What is the biotransformation of a drug?

A

Enzyme-catalyzed chemical transformation, and more than one pathway may be involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is first pass metabolism?

A

Metabolism in the intestinal mucosa or liver, which occurs before (some) orally administered drugs reach systemic circulation

If drugs are substantially metabolized before reaching systemic circulation, they have been exposed to the “first pass effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is entero-hepatic recycling? What effect does it have on the half-life of a drug?

A

The continuing cycle of biliary secretion and intestinal reabsorption. This can prolong the half-life of a drug and create a delayed second peak in [drug].

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the consequences of drug metabolism? Are drugs ever given in an inactive form?

A

Active drug –> Inactive metabolite

Active drug –> Active metabolite

Inactive drug (prodrug) –> Active metabolite

Active drug –> Toxic metabolite

Inactive drugs (prodrugs) can be given to delay activity in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the sites of first-pass metabolism?

A

The liver and GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are common intracellular sites of drug-metabolizing enzymes?

A

SER

Mitochondria

Cytosol

Lysosomes

Nuclear envelope

Plasma membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are Phase I reactions?

A

Oxication (microsomal, P450-mediated, and nonmicrosomal, non P450-mediated)

Reduction

Hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are Phase II reactions?

A

Conjugation reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What enzymes are involved in Phase I microsomal oxidation?

A

Cytochrome P450, a Mixed Function Oxidase System (MFO) which is found in the liver, intestinal mucosa, lung, kidney, and skin (SER is primary source)

also flavin mono-oxygenase (FMO3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the isozymes of Cytochrome P450?

A

CYP1A2

CYP2B6

CYP2C8, CYP2C9, CYP2C19

CYP2D6

CYP2E1

CYP3A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the general characteristics of P450s?

A

Small differences in AA sequences lead to important differences in metabolism. They also have genetic variability in expression.

They are inhibited by commonly used drugs, and also are inducible, with the exception (possibly) of CYP2D6, by things like foods, cigarette smoke, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the three key elements that influence CYP enzymes?

A

Substrates, which are drugs that the enzyme can metabolize

Inhibitors, ususally drugs meant as substrates for other pathways that can inhibit a separate CYP enzyme

Inducers, usually food, environmental elements (cigarette smoke), or other drugs that can activate a different CYP enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What CYP enzymes differ in their amounts across different groups? What is the average % difference in amount, and in what populations?

A

CYP2C9 - absent in 1% of Caucasians

CYP2C19 - absent in 20-30% of Asians, and 3-5% of Caucasians

CYP2D6 - absent in 7% of Caucasians, hyperactive in 30% of East Africans, hyperactive in up to 10% of Western Europeans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the significance of the tizanidine-fluvoxamine interaction? What enzyme is involved?

A

CYP1A2 is involved in the metabolism of tizanidine. Fluvoxamine acts as a potent inhibitor of CYP1A2. When tizanidine was given alone (open circles), [tizanidine] is much lower. When given with fluvoxamine, however, CYP1A2 was inhibited, so [tizanidine] was 12x higher.

Open circles are fluvoxamine alone, closed are with tizanidine (see graph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the function of tizanidine?

A

It decreases blood pressure by decreasing systolic & diastolic pressure as well as heart rate. It also causes sedation.

Fluvoxamine alone is in open circles, with tizanidine is in closed circles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What enzyme processes codeine, and how does it conduct this process chemically? What is notable about it?

A

CYP2D6. It is absent in 7% of Caucasians, and is hyperactive in 30% of East Africans and 10% of Western Europeans. It converts codeine to morphine, which is an analgesic. Those with polymorphisms do not get the benefit from CYP2D6.

CYP2D6 is responsible for the O-demethylation of codeine to morphine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What can happen to individuals who metabolize codeine too rapidly?

A

CYP2D6 overactivity in East Africans (30%) and Western Europeans (10%) can lead to codeine intoxication, with blood levels of morphine 20-80x higher than expected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How can you test the phenotype of CYP2D6 to determine if the pt has multiple copies/high amounts of the gene/protein?

A

Administering dextromethorphan (a nontoxic cough suppressant) and analyzing its rate of metabolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why shouldn’t new mothers breastfeed babies if they are taking codeine?

A

The metabolite of CYP2D6, morphine, which is converted from codeine, will end up in breastmilk and be transferred to the baby, causing toxic concentrations of morphine to build up in the babies’ system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why is it important to ask a patient if they are taking supplements, in addition to prescription drugs?

A

Some supplements, like St. John’s Wort, are inducers of CYP enzymes (CYP3A, in this case) and can increase the mebatolism of drugs like indinavir, an HIV treatment (see graph for reference)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are nonmicrosomal oxidations that can occur in drugs?

A

Alcohol dehydrogenase

Aldehyde dehydrogenase

Purine oxid.

Monoamine oxid.

22
Q

If someone had methanol (or ethylene glycol) poisoning, why would you give ethanol as a treatment?

A

Ethanol competes with alcohol dehydrogenase, blocking at least some of it’s activity in converting methanol to formaldehyde.

23
Q

How do you block purine oxidation?

A

Hypoxanthine oxidation to uric acid via xanthine oxidase can be blocked by our good friend, allopurinol.

24
Q

What can block monoamine oxidase? What do they do?

A

Since monoamine oxidase (MAO) degrades serotonin, MAO inhibitors can be given as antidepressants

25
Q

What enzymes mediate hydrolysis reactions?

A

Esterases in plasma, liver and other tissues

Amidases in liver and gut flora

26
Q

What endogenous substrates can drugs be conjugated to?

A

Glucuronic acid

Acetic acid

Glutathione

Sulfuric acid

Methyl groups

27
Q

What enzyme conjugates glucuronide?

A

UDP glucuronyl transferase (UGT)

28
Q

What enzyme conjugates acetyl groups?

A

Acetyl transferase

29
Q

What enzyme conjugates glutathione?

A

Glutathione S-transferases

30
Q

What enzyme conjugates sulfur groups?

A

Sulfotransferases

31
Q

What enzymes mediate methylation?

A

Methyltransferases

32
Q

What effect do transporters have on pharmacokinetics?

A

They transport drugs and other substances in and out of cells

They may control absorption, distribution and elimination

They may work in concert with metabolizing enzymes

The may be involved in drug interactions

33
Q

What is a key transporter that is located in the apical membrane of may key tissues? What tissues are these?

A

The P-glycoprotein (P-gp, a Multi-Drug Resistance [MDR1] protein) is located in the membranes of intestine, liver, kidney and BBB tissues

It prevents entry and toxicity of compounds into the blood, brain, etc.

34
Q

What P450 analog interacts with/is co-expressed with P-gp?

A

P-glycoprotein is co-expressed with CYP3A4, an intracellular enzyme that is induced by St. John’s wort, rifampin and ritonavir. This enzyme helps mediate P-gp activity and prevents too much of a drug or toxin from entering the blood.

35
Q

What effects does the inhibition of drug metabolism have?

A

It can result in toxicity (active –> toxic) or therapeutic failure (prodrug –> active).

It will most likely inhibit Phase I pathways.

Drugs with common pathways might interact, although not all inhibitors are substrates for a drug’s given processing enzyme. Some may be allosteric-esque inhibitors that affect the enzyme outside of it’s direct interaction with a drug.

There are also food-drug interactions and tobacco-drug interactions that can inhibit a drug’s effect.

36
Q

What are the consequences of induction of drug metabolism?

A

Can result in toxicity and therapeutic failure (as with indinavir and St. John’s wort). Other drugs can induce drug metabolism, as can herbal supplements and environmental factors.

37
Q

What are some endogenous influences on drug metabolism?

A

Pharmacogenetics (i.e. an individual’s genetic makeup that may/may not allow them to produce enzymes for drug metabolism)

Disease - liver disease and heart failure

Aging - pediatric (Phase I/II slower/absent in neonates) and geriatric (highly extracted drugs, primarly Phase I reactions)

Sex - CYP3A differences in males and females

38
Q

What is pharmacogenomics?

A

Study of all the genes that determine drug behavior

39
Q

What is pharmacogenetics?

A

The study of inherited differences in drug metabolism and response

40
Q

What are genetic polymorphisms? What is a SNP?

A

Differences in DNA sequences that occur naturally in a population with a frequency of >1%

Single Nucleotide Polymorphism (SNP) is a polymorphism where alleles differ by a replacement of a single nucleotide in the DNA sequence

41
Q

How can you examine the pharmacogenetics of an individual? Why is this useful?

A

There are rapid microarray tests that allow for the genomics of an individual to be assessed for CYP450-related genes, for example. This can allow individuals to be put on doseages that are relevant to their enzymatic processivity, and decrease the likelihood of being put on a drug that will become toxic due to metabolic issues with a genetic deficiency or excess.

42
Q

What is the effect of 6-mercaptopurine in bone marrow? What kind of drug is it, and how does it relate to TPMT?

A

It is an immunosuppressant cancer drug that causes a decrease in bone marrow activity, resulting in decreased RBC, WBC and platelet count. Those who are deficient in thiopurol methyltransferase (TPMT), the enzyme that metabolizes 6MP, require decreased 6MP doses to prevent toxicity.

43
Q

What is thioridazine and what enzyme processes it? What issues can arize from its use?

A

It a mood disorder treatment processed by the P450 analog CYP2D6. However, it has a VERY serious side effect of prolonging the QTc interval (heart muscle de/repolarization), and causing arrythmias and sudden death!

44
Q

What does Warfarin do, what enzyme processes it, and what are genetic issues that arise from it’s use?

A

Warfarin is a anticoagulant that is metabolized by S-CYP2C9. However,genetic variants are associated with a DECREASED requirement for Warfarin, and if given in normal doses in these ptscan cause internal bleeding.

45
Q

What is Abacavir used to treat, and what pharmacogenetic issues are associated with it?

A

Used to treat HIV-1 infection, and HLA-B*5701 gene is associated with potentially fatal hypersensitivity reactions

46
Q

What is Carbamazepine used to treat, and what are some potential pharmacogenetic side effects of it?

A

Used to treat seizures, mania/bipolar disease, and neuropathic pain. HLA-B*1502 gene is associated with a severe skin reaction called Stevens Johnson Syndrome (SJS), especially in Han Chinese populations

47
Q

What is Valproic acid used to treat, and what are the associated pharmacogenetics of it?

A

Used to treat seizures, and POLG gene mutations (neurometabolic syndromes) cause increased risk of valproic acid-induced liver failure.

48
Q

What is epigenetics?

A

Changes in gene expression caused by DNA modifications, without changes in the actual DNA sequence. These changes occur due to…

DNA methylation

Histone modification

RNA activity

49
Q

What is the difference between pharmacogenetics and epigenetics?

A

Epigenetics is the difference in phenotypic expression of certain genes due to DNA modification, i.e. the differential expression of certain proteins.

Pharmacogenetics is the differential expression of certain enzymes that relate to drug metabolism, and is, in a way, a subset of epigenetics (i.e. polymorphisms in certain genes, which are actual changes to DNA)

50
Q

What is epigenetics associated with?

A

Cancer

Mental retardation

Autoimmune disease

Neuropsychiactric disease

51
Q

How have drug targets been used in combination with epigenetics?

A

Analysis of the presence of cancer-causing DNMTs (DNA methyltransferases) and HDACs (histone deacetylases) can be used to assess if drugs that treat overactivity of either are needed. For example, if tumor suppressor genes are methylated, drugs like Azacitidine and Decitabine can be used to treat cancers caused by their methylation.

52
Q

What aspects of drug metabolism play a role in the framework for pharmacology?

A

Mechanism of action

Elimination

Pharmacogenetics

Drug interactions

Adverse drug reactions